Titan Pharmaceuticals Files Definitive Proxy Statement
| Field | Detail |
|---|---|
| Company | Titan Pharmaceuticals Inc |
| Form Type | DEF 14A |
| Filed Date | May 2, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
Related Tickers: TTNP
TL;DR
Titan Pharma (TTNP) proxy filed. Annual meeting June 16. Vote your shares!
AI Summary
Titan Pharmaceuticals, Inc. filed its definitive proxy statement (DEF 14A) on May 2, 2025, for its annual meeting on June 16, 2025. The filing outlines information required for the proxy statement, including details for shareholders to vote on company matters. Titan Pharmaceuticals is in the biological products sector and is incorporated in Delaware.
Why It Matters
This filing is crucial for shareholders as it details the agenda and proposals for the upcoming annual meeting, enabling them to exercise their voting rights on corporate governance and other important company decisions.
Risk Assessment
Risk Level: low — A DEF 14A filing is a routine disclosure document for public companies and does not inherently represent new financial risk.
Key Players & Entities
- TITAN PHARMACEUTICALS INC (company) — Registrant
- 0001829126-25-003316 (filing_id) — Accession Number
- 20250502 (date) — Filing Date
- 20250616 (date) — Meeting Date
- 400 OYSTER POINT BLVD SUITE 505 (address) — Company Business Address
- SAN FRANCISCO, CA 94080 (address) — Company Business Address
- 6502444990 (phone) — Company Business Phone
FAQ
What is the purpose of this DEF 14A filing?
The purpose of this DEF 14A filing is to provide shareholders with the information required in a proxy statement for the annual meeting of Titan Pharmaceuticals, Inc.
When was this definitive proxy statement filed?
This definitive proxy statement was filed on May 2, 2025.
What is the date of the annual meeting for which this proxy statement is being issued?
The annual meeting for which this proxy statement is being issued is scheduled for June 16, 2025.
What is the company's primary business sector?
The company's primary business sector is Biological Products (No Diagnostic Substances) [2836].
Where is Titan Pharmaceuticals, Inc. incorporated?
Titan Pharmaceuticals, Inc. is incorporated in Delaware (DE).
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on May 2, 2025 regarding TITAN PHARMACEUTICALS INC.